General Hospital Slovenj Gradec

Slovenj Gradec SI 2380

1 studies enrolling now · 5 studies all time

What they study most

Fabry Disease

Studies at this site

• A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients — Recruiting now
• Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease — Completed
• Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function — Completed
• Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease — Completed
• Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease — Completed